Please select the option that best describes you:
Given the different rates of testosterone recovery, do you alter the duration of ADT when using Leuprorelin (GnRH Agonist) vs relugolix (GnRH antagonist) in patients with intermediate or high-risk prostate cancer who received definitive radiation?
Excellent points Dr. @Patel. Would add one counter...
Great summary, good links. Like Dr. @Janopaul-Nayl...
Great points - I agree patient preferences are com...
The payment issue was a big deal for us a couple o...